Unconditional sales contract of Rua manufacturing facility

MKTUPDTE
Thu, Oct 31 2024 09:33 am

At the time of this release Rua Bioscience has not received the settlement funds from the the purchaser, Awa Ora Genesis Kaitiaki Harakeke Trust of Te Araroa, for the purchase of the Gisborne manufacturing facility.

The contract is for $1.3 mill and was due to be paid in full by 5pm yesterday, 30th October 2024.

The Board have received assurances from the Trust that they intend to complete the purchase of the property and have requetsed further time before settlement.

The Board is now considering their legal options in this situation and are also in parallel working with other credible parties on an alternate purchase plan.

The Board will update the market as soon as new information is received.


ENDS  

The person who authorised this announcement:

Paul Naske
Chief Executive Officer
[email protected]
+64 21 445154


Announcement PDF


Markets News

From banking to boardrooms: director Shelley Ruha
Markets Small Cap Wrap

From banking to boardrooms: director Shelley Ruha

Why this small-cap chair loves littlies, rural optimism, boomer farm sales, and more.

Markets Market Close

GDP beats forecasts, but NZ sharemarket dips

Energy gentailers have agreed general terms for an energy reserve at Huntly.

Tom Raynel 19 Jun 2025
GDP beats forecasts, but NZ sharemarket dips
Retail

KMD Brands dips 5% on ‘disappointing’ update

The downgrade was driven by a 6.4% drop in Kathmandu sales.

Gregor Thompson 19 Jun 2025
KMD Brands dips 5% on ‘disappointing’ update